Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 10 09:53AM ET
0.3063
Dollar change
-0.0117
Percentage change
-3.67
%
Index- P/E- EPS (ttm)-8.82 Insider Own6.16% Shs Outstand8.09M Perf Week-29.72%
Market Cap2.48M Forward P/E- EPS next Y-0.90 Insider Trans0.00% Shs Float7.59M Perf Month-59.64%
Income-13.24M PEG- EPS next Q-0.27 Inst Own1.90% Short Float4.15% Perf Quarter-61.71%
Sales0.00M P/S- EPS this Y74.56% Inst Trans85.35% Short Ratio0.10 Perf Half Y-57.16%
Book/sh-0.42 P/B- EPS next Y72.73% ROA-198.45% Short Interest0.32M Perf Year-91.30%
Cash/sh0.00 P/C123.79 EPS next 5Y- ROE-594.46% 52W Range0.30 - 5.48 Perf YTD-90.43%
Dividend Est.- P/FCF- EPS past 5Y-20.69% ROI- 52W High-94.41% Beta0.92
Dividend TTM- Quick Ratio0.08 Sales past 5Y0.00% Gross Margin- 52W Low1.10% ATR (14)0.08
Dividend Ex-Date- Current Ratio0.08 EPS Y/Y TTM24.11% Oper. Margin- RSI (14)22.99 Volatility9.99% 17.71%
Employees7 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price3.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q91.58% Payout- Rel Volume0.26 Prev Close0.32
Sales Surprise- EPS Surprise0.00% Sales Q/Q- EarningsNov 12 Avg Volume3.19M Price0.31
SMA20-39.62% SMA50-47.35% SMA200-79.97% Trades Volume88,010 Change-3.67%
Nov-22-24 08:30AM
Nov-21-24 04:05PM
Nov-18-24 10:23AM
Nov-15-24 04:09PM
Nov-13-24 09:15AM
08:30AM Loading…
Nov-05-24 08:30AM
Aug-13-24 07:30AM
Aug-08-24 07:30AM
Jul-24-24 07:30AM
Jul-10-24 12:08PM
11:45AM
11:29AM
07:30AM
Jul-08-24 12:36PM
11:56AM
07:30AM Loading…
07:30AM
Jun-18-24 07:37AM
May-29-24 07:30AM
May-15-24 01:55PM
08:36AM
08:20AM
08:14AM
08:00AM
07:29AM
May-13-24 10:53PM
04:10PM
Apr-30-24 07:30AM
Apr-24-24 02:52PM
Mar-26-24 07:30AM
Feb-27-24 07:31AM
07:30AM Loading…
07:30AM
Feb-07-24 07:30AM
Dec-29-23 07:30AM
Nov-17-23 07:10AM
07:00AM
Nov-15-23 04:15PM
Oct-31-23 08:58AM
Oct-12-23 08:02AM
Oct-02-23 08:58AM
Sep-27-23 08:58AM
Sep-26-23 08:58AM
Sep-22-23 11:27AM
Sep-21-23 10:00AM
Sep-18-23 07:58AM
Sep-05-23 09:00AM
Aug-28-23 08:58AM
Aug-14-23 09:00AM
Aug-10-23 08:58AM
Jul-24-23 07:00AM
Jul-13-23 08:58AM
Jun-21-23 08:00AM
Jun-20-23 04:10PM
Jun-13-23 08:58AM
May-12-23 04:08PM
May-10-23 07:15AM
May-09-23 07:15AM
May-04-23 08:58AM
May-02-23 03:30PM
Apr-27-23 08:58AM
Apr-05-23 08:58AM
Mar-28-23 08:58AM
Mar-22-23 08:58AM
Feb-13-23 08:58AM
Jan-31-23 08:58AM
Jan-18-23 09:00AM
Jan-10-23 09:00AM
Jan-04-23 09:00AM
Dec-14-22 09:00AM
Nov-09-22 09:00AM
Oct-13-22 06:29AM
Aug-24-22 09:00AM
Aug-15-22 09:00AM
Jul-22-22 11:32AM
Jul-05-22 09:00AM
Jul-01-22 04:04PM
06:33AM
Jun-30-22 06:44AM
04:00AM
Jun-29-22 04:06PM
11:30AM
09:32AM
Jun-28-22 07:08PM
05:01PM
04:37PM
11:14AM
Jun-27-22 12:13PM
09:00AM
Jun-24-22 12:25PM
Jun-23-22 04:34PM
04:00AM
May-19-22 09:00AM
May-16-22 09:00AM
May-06-22 06:12AM
May-05-22 09:00AM
Apr-26-22 09:00AM
Mar-31-22 09:00AM
Mar-22-22 09:00AM
04:00AM
Mar-15-22 01:45PM
10:06AM
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.